BioCentury | Apr 13, 2018
Financial News

Mimetas raises $20.5M in series B

...Organ-on-a-chip company Mimetas B.V. (Leiden, the Netherlands) raised $20.5 million on April 11 in a series B...
...Fund II, Korys, Cathay Venture and InnovationQuarter also participated, as did existing investor Oost NL. Mimetas...
...cells and iPS cells (see BioCentury Innovations, March 8) . Mimetas B.V., Leiden, the Netherlands Elizabeth S. Eaton Mimetas B.V....
BioCentury | Mar 9, 2018
Product R&D

Chips for tox

...culture; iPS cells Hurel Corp. Hurelhuman and seven other species of hepatic models Primary hepatocytes Mimetas B.V....
BioCentury | Dec 6, 2017
Emerging Company Profile

Building up nerve

...two other companies are using human cells to create in vitro models of neural tissue. Mimetas B.V....
...glia. Emulate Inc. is developing various organs on chips models, including one of the brain. Mimetas...
...None issued Companies and Institutions Mentioned AxoSim Technologies, New Orleans, La. Emulate Inc., Cambridge, Mass. Mimetas B.V....
BioCentury | Aug 23, 2017
Distillery Techniques

Assays and screens; drug properties

...aspirin or staurosporine had dose- and time-dependent effects on epithelial barrier disruption. Next steps by Mimetas B.V....
...published online Aug. 15, 2017 doi:10.1038/s41467-017-00259-3 CONTACT: Paul Vulto, Mimetas B.V., Leiden, the Netherlands email: p.vulto@mimetas.com Michael Leviten Mimetas B.V....
BioCentury | Aug 27, 2015
Strategy

Abandoning linear thinking

...and BBB chips (not shown). TissUse GmbH is developing multi-organ chips, including a liver-skin chip. Mimetas B.V....
BioCentury | Jan 15, 2015
Finance

Consortia cross-talk

...$119.1 million) Develop antibacterial research programs through discovery and Phase I testing 2014 Mimetas consortium Mimetas B.V....
BioCentury | Nov 20, 2014
Tools & Techniques

HemoShear's human touch

...in vivo human biology include the microfluidics-based organ-on-a-chip models being developed by Emulate Inc. , Mimetas B.V....
...N.J. Medivir AB (SSE:MVIR B), Huddinge, Sweden Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Mimetas B.V....
BioCentury | Oct 13, 2014
Company News

Mimetas, National Center for the Replacement, Radboud University Nijmegen Medical Center, University of Applied Sciences and Arts Northwestern Switzerland suppl

...The U.K.'s NC3Rs awarded a consortium comprising Mimetas and the universities $1.6 million to develop a...
...development. The consortium will combine Mimetas' OrganoPlate 3D-culturing technology with a human renal cell line. Mimetas B.V....
BioCentury | Oct 13, 2014
Financial News

Mimetas completes venture financing

Mimetas B.V. , Leiden, the Netherlands Business: Microfluidics Date completed: 2014-10-08 Type: Venture financing Raised: $5.2 million Investors: PPM Oost; Zeeuws InvesteringsFonds WIR Staff...
BioCentury | Sep 22, 2014
Emerging Company Profile

Emulate: Organs on chips

...Mimetas B.V. , and Nortis Inc. TissUse launched a cell culture-based organ chip in 2013. Mimetas...
...plc (LSE:GSK; NYSE:GSK), London, U.K. Emulate Inc. , Cambridge, Mass. Harvard University , Cambridge, Mass. Mimetas B.V....
Items per page:
1 - 10 of 12
BioCentury | Apr 13, 2018
Financial News

Mimetas raises $20.5M in series B

...Organ-on-a-chip company Mimetas B.V. (Leiden, the Netherlands) raised $20.5 million on April 11 in a series B...
...Fund II, Korys, Cathay Venture and InnovationQuarter also participated, as did existing investor Oost NL. Mimetas...
...cells and iPS cells (see BioCentury Innovations, March 8) . Mimetas B.V., Leiden, the Netherlands Elizabeth S. Eaton Mimetas B.V....
BioCentury | Mar 9, 2018
Product R&D

Chips for tox

...culture; iPS cells Hurel Corp. Hurelhuman and seven other species of hepatic models Primary hepatocytes Mimetas B.V....
BioCentury | Dec 6, 2017
Emerging Company Profile

Building up nerve

...two other companies are using human cells to create in vitro models of neural tissue. Mimetas B.V....
...glia. Emulate Inc. is developing various organs on chips models, including one of the brain. Mimetas...
...None issued Companies and Institutions Mentioned AxoSim Technologies, New Orleans, La. Emulate Inc., Cambridge, Mass. Mimetas B.V....
BioCentury | Aug 23, 2017
Distillery Techniques

Assays and screens; drug properties

...aspirin or staurosporine had dose- and time-dependent effects on epithelial barrier disruption. Next steps by Mimetas B.V....
...published online Aug. 15, 2017 doi:10.1038/s41467-017-00259-3 CONTACT: Paul Vulto, Mimetas B.V., Leiden, the Netherlands email: p.vulto@mimetas.com Michael Leviten Mimetas B.V....
BioCentury | Aug 27, 2015
Strategy

Abandoning linear thinking

...and BBB chips (not shown). TissUse GmbH is developing multi-organ chips, including a liver-skin chip. Mimetas B.V....
BioCentury | Jan 15, 2015
Finance

Consortia cross-talk

...$119.1 million) Develop antibacterial research programs through discovery and Phase I testing 2014 Mimetas consortium Mimetas B.V....
BioCentury | Nov 20, 2014
Tools & Techniques

HemoShear's human touch

...in vivo human biology include the microfluidics-based organ-on-a-chip models being developed by Emulate Inc. , Mimetas B.V....
...N.J. Medivir AB (SSE:MVIR B), Huddinge, Sweden Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Mimetas B.V....
BioCentury | Oct 13, 2014
Company News

Mimetas, National Center for the Replacement, Radboud University Nijmegen Medical Center, University of Applied Sciences and Arts Northwestern Switzerland suppl

...The U.K.'s NC3Rs awarded a consortium comprising Mimetas and the universities $1.6 million to develop a...
...development. The consortium will combine Mimetas' OrganoPlate 3D-culturing technology with a human renal cell line. Mimetas B.V....
BioCentury | Oct 13, 2014
Financial News

Mimetas completes venture financing

Mimetas B.V. , Leiden, the Netherlands Business: Microfluidics Date completed: 2014-10-08 Type: Venture financing Raised: $5.2 million Investors: PPM Oost; Zeeuws InvesteringsFonds WIR Staff...
BioCentury | Sep 22, 2014
Emerging Company Profile

Emulate: Organs on chips

...Mimetas B.V. , and Nortis Inc. TissUse launched a cell culture-based organ chip in 2013. Mimetas...
...plc (LSE:GSK; NYSE:GSK), London, U.K. Emulate Inc. , Cambridge, Mass. Harvard University , Cambridge, Mass. Mimetas B.V....
Items per page:
1 - 10 of 12